Controlled Trial of BudesonideāFormoterol as Needed for Mild Asthma | NEJM
In double-blind, placebo-controlled trials, budesonideāformoterol used on an as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β2-agonis...
nejm.org